Tenpoint Therapeutics
Last verified 2026-05-19. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $120.0Mattributed |
|---|---|
| Latest round | series-b, $85.0M, 2026-01-29attributed |
| Founded | 2017 |
| Headquarters | San Diego |
| Industry | healthcare |
| Stage | series-b+ |
| Website | tenpointtx.com |
Tenpoint Therapeutics is a biopharmaceutical company developing treatments for age-related vision conditions including presbyopia, cataracts, and geographic atrophy. It serves patients with age-related near vision loss. Its differentiator is optimizing for functional near vision, all-day duration of effect, and long-term tolerability.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-01-29 | series-b | $85.0M | undisclosed |
Detected tech stack
Nginx, WordPress, Yoast SEO 27.3, Google Tag Manager, jQuery Migrate 3.4.1, jsDelivr, Elementor 4.0.1, Pantheon, CookieYes, Varnish, PHP, MariaDB
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series B, $85.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $120.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | tenpointtx.com, read 2026-05-19 |
| Description | self-reported | tenpointtx.com, read 2026-05-19 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.